Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POSIMIR for Postoperative Pain Control in Abdominal Hysterectomy
NCT00993226Phase 2Completed
- Sponsor
- DURECT Corporation
- Start
- May 2009
- Primary completion
- Dec 2009
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
Phase 2, randomised, double-blind trial of bimatoprost in postoperative pain (6 arms), sponsored by DURECT Corporation. Primary endpoints: Pain Intensity at 72 hours and Supplemental Opioid Use at 3 days. Started May 2009; status: completed.
02
Drugs
bimatoprost
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00993226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00993226.